The role of outsourcing in antibody drug manufacture
European Pharmaceutical Review
APRIL 8, 2024
A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.
Let's personalize your content